In Orexo AB v. Actavis Elizabeth LLC [2017-1333](September 10, 2018), the Federal Circuit reversed the district court’s determination that the challenged claims of U.S. Patent No. 8,940,330 were invalid for obviousness. The invention related to pills for treating opiod addition, … Continue reading Just Because Seldom was Heard a Discouraging Word Did Not Mean The Invention Was Obvious